153 related articles for article (PubMed ID: 9686375)
1. Severe 5-fluorouracil toxicity caused by reduced dihydropyrimidine dehydrogenase activity due to heterozygosity for a G-->A point mutation.
van Kuilenburg AB; Vreken P; Beex LV; De Abreu RA; van Gennip AH
J Inherit Metab Dis; 1998 Jun; 21(3):280-4. PubMed ID: 9686375
[No Abstract] [Full Text] [Related]
2. Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity.
Van Kuilenburg AB; Vreken P; Beex LV; Meinsma R; Van Lenthe H; De Abreu RA; Van Gennip AH
Adv Exp Med Biol; 1998; 431():293-8. PubMed ID: 9598078
[No Abstract] [Full Text] [Related]
3. Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.
Raida M; Schwabe W; Häusler P; Van Kuilenburg AB; Van Gennip AH; Behnke D; Höffken K
Clin Cancer Res; 2001 Sep; 7(9):2832-9. PubMed ID: 11555601
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene.
van Kuilenburg AB; Haasjes J; Richel DJ; Zoetekouw L; Van Lenthe H; De Abreu RA; Maring JG; Vreken P; van Gennip AH
Clin Cancer Res; 2000 Dec; 6(12):4705-12. PubMed ID: 11156223
[TBL] [Abstract][Full Text] [Related]
5. Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity.
Van Kuilenburg AB; Vreken P; Beex LV; Meinsma R; Van Lenthe H; De Abreu RA; van Gennip AH
Eur J Cancer; 1997 Nov; 33(13):2258-64. PubMed ID: 9470816
[TBL] [Abstract][Full Text] [Related]
6. [Detection of DPD-exon-14 skipping before 5-fluorouracil treatment?].
Kliche KO
Dtsch Med Wochenschr; 2002 Mar; 127(9):463-4. PubMed ID: 11870563
[No Abstract] [Full Text] [Related]
7. [Severe capecitabine-associated toxicity in a patient carrying a mutation in the dihydropyrimidine dehydrogenase gen].
González-Haba E
Farm Hosp; 2012; 36(6):554-5. PubMed ID: 23461455
[No Abstract] [Full Text] [Related]
8. Lethal 5-fluorouracil toxicity associated with a novel mutation in the dihydropyrimidine dehydrogenase gene.
van Kuilenburg AB; Baars JW; Meinsma R; van Gennip AH
Ann Oncol; 2003 Feb; 14(2):341-2. PubMed ID: 12562666
[No Abstract] [Full Text] [Related]
9. [Detection of DPD exon 14 skipping before fluorouracil treatment].
Steiner M; Schuff-Warner P; Hartung G
Dtsch Med Wochenschr; 2002 Oct; 127(42):2223. PubMed ID: 12397554
[No Abstract] [Full Text] [Related]
10. Identification of novel mutations in the dihydropyrimidine dehydrogenase gene in a Japanese patient with 5-fluorouracil toxicity.
Kouwaki M; Hamajima N; Sumi S; Nonaka M; Sasaki M; Dobashi K; Kidouchi K; Togari H; Wada Y
Clin Cancer Res; 1998 Dec; 4(12):2999-3004. PubMed ID: 9865912
[TBL] [Abstract][Full Text] [Related]
11. Correspondence re: Raida, M. et al., prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls.
Innocenti F; Ratain MJ
Clin Cancer Res; 2002 May; 8(5):1314; author reply 1315-6. PubMed ID: 12006555
[No Abstract] [Full Text] [Related]
12. Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfecta.
Beuzeboc P; Pierga JY; Stoppa-Lyonnet D; Etienne MC; Milano G; Pouillart P
Eur J Cancer; 1996 Feb; 32A(2):369-70. PubMed ID: 8664058
[No Abstract] [Full Text] [Related]
13. [Severe toxicity after treatment with capecitabine and fluorouracil due to partial dihydropyrimidine dehydrogenase deficiency].
Hooiveld EA; van Kuilenburg AB; Haanen JB; Westermann AM
Ned Tijdschr Geneeskd; 2004 Mar; 148(13):626-8. PubMed ID: 15083629
[TBL] [Abstract][Full Text] [Related]
14. Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene.
Maring JG; van Kuilenburg AB; Haasjes J; Piersma H; Groen HJ; Uges DR; Van Gennip AH; De Vries EG
Br J Cancer; 2002 Apr; 86(7):1028-33. PubMed ID: 11953843
[TBL] [Abstract][Full Text] [Related]
15. Common DPYD mutation associated with 5-fluorouracil toxicity detected by PCR-mediated site-directed mutagenesis.
Jézéquel P; Joalland MP; Milano G; Lanoë D; Ricolleau G; Marie-Christine E; Deporte-Fety R
Clin Chem; 2000 Feb; 46(2):309-10. PubMed ID: 10657402
[No Abstract] [Full Text] [Related]
16. Increased risk of grade IV neutropenia after administration of 5-fluorouracil due to a dihydropyrimidine dehydrogenase deficiency: high prevalence of the IVS14+1g>a mutation.
Van Kuilenburg AB; Meinsma R; Zoetekouw L; Van Gennip AH
Int J Cancer; 2002 Sep; 101(3):253-8. PubMed ID: 12209976
[TBL] [Abstract][Full Text] [Related]
17. [A case of gastric cancer with decreased dihydropyrimidine dehydrogenase activity].
Kobayashi K; Sumi S; Kidouchi K; Mizuno I; Mohri N; Fukui T; Akamo Y; Takeyama H; Manabe T
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1217-9. PubMed ID: 9679586
[TBL] [Abstract][Full Text] [Related]
18. Dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil associated toxicity.
van Kuilenburg AB; Haasjes J; Van Lenthe H; Zoetekouw L; Waterham HR; Vreken P; van Gennip AH
Adv Exp Med Biol; 2000; 486():251-5. PubMed ID: 11783494
[No Abstract] [Full Text] [Related]
19. Increased dihydropyrimidine dehydrogenase activity associated with mild toxicity in patients treated with 5-fluorouracil and leucovorin.
van Kuilenburg AB; Klumpen HJ; Westermann AM; Zoetekouw L; Van Lenthe H; Bakker PJ; Richel DJ; Guchelaar HJ
Eur J Cancer; 2007 Jan; 43(2):459-65. PubMed ID: 17097873
[TBL] [Abstract][Full Text] [Related]
20. Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil.
Johnson MR; Hageboutros A; Wang K; High L; Smith JB; Diasio RB
Clin Cancer Res; 1999 Aug; 5(8):2006-11. PubMed ID: 10473079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
